Looking for a world-class partner for your preclinical studies? You found us!

In order to minimize and sometimes even eliminate adverse effects of clinical drugdevelopment testing in humans, preclinical studies allow early filtering of those drugs that are simply too toxic or unsafe to continue.

A vital and necessary process in order to calculate the starting dose for the testing of a drug in human trials, and indeed a necessary requirement by the FDA, preclinical trials on animals provide manufacturers a safe and much quicker option to enhance their studies and ultimately bring new beneficial medicines to the market.

Offering a comprehensive end-to-end service in collaboration with a strategic partner, QUINTA-ANALYTICA can offer everything from preclinical development to toxicological (TK) studies. With our own in-house pharma labs, our Bioanalytical Services department also offers testing of the application form of the drug to guarantee compliance with the exact drug specification.

The result is a partner you can trust to guide you from A-Z throughout the preclinical process and onward to full human clinical trials.

Get in touch with our team to find out more.

Additional News

  • 18 September 2024

    Determination of total bound iron in human blood serum samples

    Ironing out the challenges: measuring total bound iron in blood serum in Ferric Carboxymaltose (FCM) Studies

  • 4 September 2024

    Meet us at the heart of Pharma at CPHI 2024

    As a part of Conscio Group, we are attending CPHI 2024 in Milan, Italy.

  • 18 March 2024

    News from our newly opened clinic in Ostrava

    Our new Clinic in Ostrava (CZ) is gaining momentum step by step; therefore, we have some interesting news for you from the center of the action.